Literature DB >> 34446109

Assessment of gait in patients with fibromyalgia during motor and cognitive dual task walking: a cross-sectional study.

Goran Radunović1, Zoran Veličković1, Melanija Rašić1, Saša Janjić1, Vladana Marković2, Saša Radovanović3.   

Abstract

BACKGROUND: The aim of the study was to assess gait pattern of patients diagnosed with fibromyalgia (FM) while performing demanding motor and/or cognitive dual tasks while walking. Further, idea was to explore possible correlations of dual task gait pattern alterations to patients' functional status and presence or absence of clinical symptoms associated with FM.
METHODS: Twenty-four female FM patients and 24 healthy female subjects performed a basic walking task, a dual motor, a dual mental (cognitive) and a combined, dual motor and cognitive task simultaneously. Quantitative spatial (stride length) and temporal (cycle time, swing time and double support time) gait parameters were measured using GAITRite walkway system and their variability was assessed. Patients underwent clinical examination including assessment of functional status, pain and fatigue level, psychiatric and cognitive manifestations.
RESULTS: The motor, cognitive and combined dual tasks affect gait performance in FM patients. Difference in tasks between FM and healthy subjects was found as double support time prolongation. Comparison of tasks showing that cycle time in FM was longer than controls and stride length was shorter in patients for all conditions, while no changes were found in any of the gait parameters variability. Further, mental/cognitive dual tasks had a larger effect than motor tasks. Correlations were also found between depression and functional status of the patients and the gait parameters.
CONCLUSIONS: Gait is affected in FM patients while dual task walking. No changes in stride-to-stride variability point that patients preserve stability in complex walking situations. Analysis of gait may provide additional information for the FM identification based on presence of clinical features and cognitive status. Correlation of dual task gait alterations with occurrence of clinical symptoms and influence of cognitive changes on gait pattern could additionally define FM subgroups.
© 2021. The Author(s).

Entities:  

Keywords:  Cycle time; GAITRite walkway system; Gait variability; Stride

Mesh:

Year:  2021        PMID: 34446109     DOI: 10.1186/s42358-021-00212-5

Source DB:  PubMed          Journal:  Adv Rheumatol        ISSN: 2523-3106


  4 in total

1.  Fibromyalgia in men: comparison of clinical features with women.

Authors:  M B Yunus; F Inanici; J C Aldag; R F Mangold
Journal:  J Rheumatol       Date:  2000-02       Impact factor: 4.666

2.  Fibromyalgia in men: comparison of psychological features with women.

Authors:  Muhammad B Yunus; Reyhan Celiker; Jean C Aldag
Journal:  J Rheumatol       Date:  2004-12       Impact factor: 4.666

3.  Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms.

Authors:  F Wolfe; K Ross; J Anderson; I J Russell
Journal:  J Rheumatol       Date:  1995-01       Impact factor: 4.666

4.  The Impact of Fibromyalgia on Disability, Anxiety, Depression, Sleep Disturbance, and Quality of Life in Patients with Migraine.

Authors:  Münevver Serdaroğlu Beyazal; Ahmet Tüfekçi; Serkan Kırbaş; Mehmet Serhat Topaloğlu
Journal:  Noro Psikiyatr Ars       Date:  2018-05-04       Impact factor: 1.339

  4 in total
  2 in total

1.  Comparison between the Impacts of Memory and Arithmetic-Based Dual Tasks on Physical Performance in Women with Fibromyalgia.

Authors:  Jesús Sánchez-Gómez; Santos Villafaina; Francisco Javier Domínguez-Muñoz; Juan Luis Leon-Llamas; Alvaro Murillo-Garcia; Narcis Gusi
Journal:  Biology (Basel)       Date:  2022-06-21

2.  Assessing Walking Programs in Fibromyalgia: A Concordance Study between Measures.

Authors:  Sofía López-Roig; Carmen Ecija; Cecilia Peñacoba; Sofía Ivorra; Ainara Nardi-Rodríguez; Oscar Lecuona; María Angeles Pastor-Mira
Journal:  Int J Environ Res Public Health       Date:  2022-03-04       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.